Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael Manns, Didier Samuel, Edward J Gane, David Mutimer, Geoff McCaughan, Maria Buti, MartÍn Prieto, José Luis Calleja, Markus Peck-Radosavljevic, Beat Müllhaupt, Kosh Agarwal, Peter Angus, Eric M Yoshida, Massimo Colombo, Mario Rizzetto, Hadas Dvory-Sobol, Jill Denning, Sarah Arterburn, Phillip S Pang, Diana BrainardJohn G McHutchison, Jean-François Dufour, Hans Van Vlierberghe, Bart van Hoek, Xavier Forns, SOLAR-2 investigators

Research output: Contribution to journal › Article › peer-review

312 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences